![3-[4-Hydroxy-3-[5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-3-(Pentyloxy)-2-Naphthalenyl]Phenyl]-2-Propenoicacid](https://static.cymitquimica.com/cas-image/404687-3-4-hydroxy-3-5678-tetrahydro-5588-tetramethyl-3-pentyloxy-2-naphthalenyl-phenyl-2-propenoicacid.png)
CAS: 847239-17-2 - 3-[4-Hydroxy-3-[5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-3-(Pentyloxy)-2-Naphthalenyl]Phenyl]-2-Propenoicacid
Formula:C28H36O4
- Synonyms:
- 3-[4-Hydroxy-3-(5,5,8,8-Tetramethyl-3-Pentoxy-6,7-Dihydronaphthalen-2-Yl)Phenyl]Prop-2-Enoic Acid
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | UVI 3003 REF: AN-AG008GQ3CAS: 847239-17-2 | ≥98% | To inquire | Wed 22 May 24 |
 | UVI 3003 REF: 54-BISN0065CAS: 847239-17-2 | 98% | 67.00 € | Thu 23 May 24 |
 | UVI 3003 REF: TM-T17209CAS: 847239-17-2 | 99.94% | 35.00 €~594.00 € | Wed 29 May 24 |
 | UVI 3003 REF: 3D-XIB23917CAS: 847239-17-2 | Min. 95% | To inquire | Wed 03 Jul 24 |
Ref: AN-AG008GQ3
| 1mg | 45.00 € | |
| 5mg | 100.00 € | |
| 10mg | 138.00 € | |
| 25mg | 192.00 € | |
| 50mg | 328.00 € | |
| 100mg | 518.00 € | |
| 250mg | To inquire |
Estimated delivery in United States, on Wednesday 22 May 2024
Ref: 54-BISN0065
| 5mg | 67.00 € |
Estimated delivery in United States, on Thursday 23 May 2024
UVI 3003
CAS:847239-17-2
UVI 3003 is a highly selective antagonist of the retinoid X receptor. UVI 3003 inhibits …
Formula:
C28H36O4
Purity:
99.94%
Color and Shape:
Solid
Molecular weight:
436.58
Ref: TM-T17209
| 1mg | 35.00 € | |
| 2mg | 52.00 € | |
| 5mg | 74.00 € | |
| 10mg | 118.00 € | |
| 25mg | 237.00 € | |
| 50mg | 398.00 € | |
| 100mg | 594.00 € | |
| 1ml*10 (DMSO) | 84.00 € |
Estimated delivery in United States, on Wednesday 29 May 2024
UVI 3003
CAS:847239-17-2
UVI 3003 is a drug that is being developed for the treatment of cancer. It …
Formula:
C28H36O4
Purity:
Min. 95%
Molecular weight:
436.58 g/mol
Ref: 3D-XIB23917
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 3 Jul 2024
